Physician profile
Alejandro J Centurion
NPI 1730593708
$4,257.00
in general payments reported to CMS, 2019-2025
14 companies · $167 in 2025
The $167 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,668 · 2020: $225 · 2021: $279 · 2022: $207 · 2023: $228 · 2024: $484 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597 · Travel and Lodging: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.99 |
| Travel and Lodging | $280.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,926.50 | 2019 | |
| Radius Health, INC. | $626.53 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $374.28 | 2024 | Iovera, Zilretta, Exparel |
| Horizon Therapeutics Plc | $339.86 | 2019-2022 | |
| Biotissue Holdings INC. | $282.03 | 2022-2025 | |
| Amgen INC. | $211.38 | 2020-2024 | Evenity, Prolia |
| Pacira Therapeutics, INC. | $155.94 | 2019-2021 | |
| Bioventus LLC | $97.82 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Dexcom, INC. | $90.00 | 2025 | Dexcom G6 Transmitter |
| Ferring Pharmaceuticals INC. | $53.83 | 2019-2021 | |
| Smith+Nephew, INC. | $35.67 | 2024 | Grafix Pl, Stravix |
| Boston Scientific Corporation | $30.63 | 2025 | Intracept |
| Southern Edge Orthopaedics, INC. | $18.01 | 2024 | |
| Depuy Synthes Sales INC. | $14.52 | 2024 | Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Centurion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.